Metformin hydrochloride extended-release tablets

DRUG3 trials

Sponsors

UConn Health, Johns Hopkins University, Shandong Suncadia Medicine Co., Ltd.

Conditions

Age-Related ImmunodeficiencyAgingAsthmaAsthma ChronicDiabetesOverweight and ObesityVaccine Response Impaired

Phase 1

Vaccination Efficacy With Metformin in Older Adults

CompletedNCT03996538

UConn HealthAge-Related Immunodeficiency, Aging, Vaccine Response Impaired

Start: 2019-06-05End: 2020-02-04Updated: 2020-07-23

Study on Drug Interaction of Metformin Tablets and HRS-7535 Tablets in Healthy Human

Not yet recruitingNCT06727838

Shandong Suncadia Medicine Co., Ltd.Diabetes

Start: 2024-12-31End: 2025-05-31Target: 54Updated: 2024-12-11

Phase 2

Metformin IN Asthma for Overweight and Obese Individuals (MINA)

RecruitingNCT06273072

Johns Hopkins UniversityAsthma, Asthma Chronic, Overweight and Obesity

Start: 2024-12-09End: 2028-12-31Target: 100Updated: 2026-01-16